Product NDC: | 51285-442 |
Proprietary Name: | Cenestin |
Non Proprietary Name: | synthetic conjugated estrogens, A |
Active Ingredient(s): | .625 mg/1 & nbsp; synthetic conjugated estrogens, A |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51285-442 |
Labeler Name: | Teva Women's Health Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020992 |
Marketing Category: | NDA |
Start Marketing Date: | 19990324 |
Package NDC: | 51285-442-02 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51285-442-02) |
NDC Code | 51285-442-02 |
Proprietary Name | Cenestin |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51285-442-02) |
Product NDC | 51285-442 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | synthetic conjugated estrogens, A |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19990324 |
Marketing Category Name | NDA |
Labeler Name | Teva Women's Health Inc. |
Substance Name | ESTROGENS, CONJUGATED SYNTHETIC A |
Strength Number | .625 |
Strength Unit | mg/1 |
Pharmaceutical Classes |